Cosmax（A192820）株式概要Cosmax, Inc.は、韓国内外で化粧品および健康機能食品の研究、開発、生産、製造を行っている。 詳細A192820 ファンダメンタル分析スノーフレーク・スコア評価6/6将来の成長2/6過去の実績4/6財務の健全性3/6配当金2/6報酬当社が推定した公正価値より50.2%で取引されている 収益は年間10.29%増加すると予測されています 過去1年間で収益は109.5%増加しました 同業他社や業界と比較して、良好な取引価格 アナリストらは、株価が37.2%上昇するだろうとほぼ一致している。 リスク分析負債は営業キャッシュフローで十分にカバーされていない 高いレベルの非現金収入 1.88%の配当はフリーキャッシュフローで十分にカバーされていない すべてのリスクチェックを見るA192820 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value₩Current Price₩175.90k10.5% 割安 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture04t2016201920222025202620282031Revenue ₩4.1tEarnings ₩258.5bAdvancedSet Fair ValueView all narrativesCosmax, Inc. 競合他社Kolmar KoreaSymbol: KOSE:A161890Market cap: ₩2.1tAMOREPACIFIC HoldingsSymbol: KOSE:A002790Market cap: ₩2.0td'Alba GlobalSymbol: KOSE:A483650Market cap: ₩2.6tCosmecca KoreaSymbol: KOSDAQ:A241710Market cap: ₩795.7b価格と性能株価の高値、安値、推移の概要Cosmax過去の株価現在の株価₩175,900.0052週高値₩287,000.0052週安値₩155,200.00ベータ0.901ヶ月の変化-22.00%3ヶ月変化-6.93%1年変化-13.14%3年間の変化121.26%5年間の変化33.76%IPOからの変化161.76%最新ニュースValuation Update With 7 Day Price Move • May 18Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to ₩180,200, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 14x in the Personal Products industry in South Korea. Total returns to shareholders of 115% over the past three years.分析記事 • Mar 25Cosmax's (KRX:192820) Solid Profits Have Weak FundamentalsCosmax, Inc.'s ( KRX:192820 ) stock was strong after they recently reported robust earnings. However, our analysis...Reported Earnings • Mar 24Full year 2025 earnings: EPS exceeds analyst expectationsFull year 2025 results: EPS: ₩10,847 (up from ₩7,562 in FY 2024). Revenue: ₩2.40t (up 11% from FY 2024). Net income: ₩123.1b (up 43% from FY 2024). Profit margin: 5.1% (up from 4.0% in FY 2024). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 95%. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 17% growth forecast for the Personal Products industry in South Korea. Over the last 3 years on average, earnings per share has increased by 41% per year but the company’s share price has only increased by 34% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Mar 23Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₩198,700, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 14x in the Personal Products industry in South Korea. Total returns to shareholders of 157% over the past three years.お知らせ • Mar 07+ 1 more updateCosmax, Inc. announces Annual dividendCosmax, Inc. announced Annual dividend of KRW 3300.0000 per share, ex-date on March 30, 2026 and record date on March 31, 2026.Valuation Update With 7 Day Price Move • Mar 04Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₩160,700, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 14x in the Personal Products industry in South Korea. Total returns to shareholders of 102% over the past three years.最新情報をもっと見るRecent updatesValuation Update With 7 Day Price Move • May 18Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to ₩180,200, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 14x in the Personal Products industry in South Korea. Total returns to shareholders of 115% over the past three years.分析記事 • Mar 25Cosmax's (KRX:192820) Solid Profits Have Weak FundamentalsCosmax, Inc.'s ( KRX:192820 ) stock was strong after they recently reported robust earnings. However, our analysis...Reported Earnings • Mar 24Full year 2025 earnings: EPS exceeds analyst expectationsFull year 2025 results: EPS: ₩10,847 (up from ₩7,562 in FY 2024). Revenue: ₩2.40t (up 11% from FY 2024). Net income: ₩123.1b (up 43% from FY 2024). Profit margin: 5.1% (up from 4.0% in FY 2024). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 95%. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 17% growth forecast for the Personal Products industry in South Korea. Over the last 3 years on average, earnings per share has increased by 41% per year but the company’s share price has only increased by 34% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Mar 23Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₩198,700, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 14x in the Personal Products industry in South Korea. Total returns to shareholders of 157% over the past three years.お知らせ • Mar 07+ 1 more updateCosmax, Inc. announces Annual dividendCosmax, Inc. announced Annual dividend of KRW 3300.0000 per share, ex-date on March 30, 2026 and record date on March 31, 2026.Valuation Update With 7 Day Price Move • Mar 04Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₩160,700, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 14x in the Personal Products industry in South Korea. Total returns to shareholders of 102% over the past three years.お知らせ • Feb 23Cosmax, Inc. (KOSE:A192820) signed a share purchase agreement to acquire 51% stake in Keminova Italiana A Responsabilita' Limitata Benefit In Breve Keminova Italiana S.B. Srl.Cosmax, Inc. (KOSE:A192820) signed a share purchase agreement to acquire 51% stake in Keminova Italiana A Responsabilita' Limitata Benefit In Breve Keminova Italiana S.B. Srl on February 23, 2026. Through this acquisition, COSMAX seeks to leverage the strengths of both companies to create significant synergies. For the period ending December 31, 2025, Keminova Italiana A Responsabilita' Limitata Benefit In Breve Keminova Italiana S.B. Srl reported total revenue of €10.5 million. COSMAX plans to satisfy the conditions precedent, including securing approval from the Italian government, by March, to finalize the transaction.Major Estimate Revision • Jan 27Consensus EPS estimates fall by 16%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate fell from ₩6,824 to ₩5,749 per share. Revenue forecast steady at ₩2.40b. Net income forecast to grow 149% next year vs 61% growth forecast for Personal Products industry in South Korea. Consensus price target broadly unchanged at ₩242,500. Share price rose 2.9% to ₩189,600 over the past week.分析記事 • Jan 02These 4 Measures Indicate That Cosmax (KRX:192820) Is Using Debt ExtensivelyHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...分析記事 • Dec 17Why Investors Shouldn't Be Surprised By Cosmax, Inc.'s (KRX:192820) P/EWhen close to half the companies in Korea have price-to-earnings ratios (or "P/E's") below 13x, you may consider...分析記事 • Nov 20We Like Cosmax's (KRX:192820) Returns And Here's How They're TrendingIf you're looking for a multi-bagger, there's a few things to keep an eye out for. One common approach is to try and...Reported Earnings • Nov 19Third quarter 2025 earnings: EPS and revenues miss analyst expectationsThird quarter 2025 results: EPS: ₩789 (down from ₩1,856 in 3Q 2024). Revenue: ₩585.6b (up 11% from 3Q 2024). Net income: ₩8.96b (down 57% from 3Q 2024). Profit margin: 1.5% (down from 4.0% in 3Q 2024). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 1.9%. Earnings per share (EPS) also missed analyst estimates by 76%. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Personal Products industry in South Korea. Over the last 3 years on average, earnings per share has increased by 29% per year but the company’s share price has increased by 41% per year, which means it is tracking significantly ahead of earnings growth.Price Target Changed • Nov 12Price target decreased by 10% to ₩256,280Down from ₩285,600, the current price target is an average from 25 analysts. New target price is 62% above last closing price of ₩158,000. Stock is up 19% over the past year. The company is forecast to post earnings per share of ₩6,484 for next year compared to ₩7,562 last year.Major Estimate Revision • Nov 11Consensus EPS estimates fall by 28%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate fell from ₩9,309 to ₩6,713 per share. Revenue forecast steady at ₩2.45b. Net income forecast to grow 92% next year vs 72% growth forecast for Personal Products industry in South Korea. Consensus price target broadly unchanged at ₩280,160. Share price fell 22% to ₩156,500 over the past week.分析記事 • Nov 05When Should You Buy Cosmax, Inc. (KRX:192820)?Cosmax, Inc. ( KRX:192820 ), is not the largest company out there, but it saw significant share price movement during...分析記事 • Sep 17Is Cosmax, Inc. (KRX:192820) Trading At A 47% Discount?Key Insights Cosmax's estimated fair value is ₩417,766 based on 2 Stage Free Cash Flow to Equity Cosmax's ₩222,500...分析記事 • Sep 03These 4 Measures Indicate That Cosmax (KRX:192820) Is Using Debt Reasonably WellLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...New Risk • Aug 19New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 23% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (2.6% operating cash flow to total debt). High level of non-cash earnings (23% accrual ratio). Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (8.6% average weekly change).Reported Earnings • Aug 19Second quarter 2025 earnings: EPS and revenues miss analyst expectationsSecond quarter 2025 results: EPS: ₩1,844 (down from ₩2,965 in 2Q 2024). Revenue: ₩623.6b (up 13% from 2Q 2024). Net income: ₩20.9b (down 38% from 2Q 2024). Profit margin: 3.4% (down from 6.1% in 2Q 2024). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 3.7%. Earnings per share (EPS) also missed analyst estimates by 38%. Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Personal Products industry in South Korea. Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has increased by 47% per year, which means it is tracking significantly ahead of earnings growth.分析記事 • Aug 14What You Can Learn From Cosmax, Inc.'s (KRX:192820) P/E After Its 27% Share Price CrashKOSE:A192820 1 Year Share Price vs Fair Value Explore Cosmax's Fair Values from the Community and select yours Cosmax...Major Estimate Revision • Aug 13Consensus EPS estimates fall by 10%The consensus outlook for earnings per share (EPS) in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from ₩2.55b to ₩2.52b. EPS estimate also fell from ₩11,353 per share to ₩10,172 per share. Net income forecast to grow 67% next year vs 32% growth forecast for Personal Products industry in South Korea. Consensus price target down from ₩295,167 to ₩288,000. Share price fell 25% to ₩191,600 over the past week.Valuation Update With 7 Day Price Move • Aug 12Investor sentiment deteriorates as stock falls 22%After last week's 22% share price decline to ₩196,600, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 17x in the Personal Products industry in South Korea. Total returns to shareholders of 188% over the past three years.分析記事 • Aug 04We Think Cosmax (KRX:192820) Might Have The DNA Of A Multi-BaggerIf we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...分析記事 • Jul 21When Should You Buy Cosmax, Inc. (KRX:192820)?Cosmax, Inc. ( KRX:192820 ), might not be a large cap stock, but it led the KOSE gainers with a relatively large price...分析記事 • Jun 23Why Investors Shouldn't Be Surprised By Cosmax, Inc.'s (KRX:192820) 29% Share Price SurgeDespite an already strong run, Cosmax, Inc. ( KRX:192820 ) shares have been powering on, with a gain of 29% in the last...Valuation Update With 7 Day Price Move • Jun 20Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₩278,500, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 14x in the Personal Products industry in South Korea. Total returns to shareholders of 397% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩393,577 per share.Price Target Changed • Jun 18Price target increased by 9.5% to ₩261,571Up from ₩238,952, the current price target is an average from 21 analysts. New target price is approximately in line with last closing price of ₩262,000. Stock is up 40% over the past year. The company is forecast to post earnings per share of ₩11,419 for next year compared to ₩7,562 last year.Price Target Changed • May 19Price target increased by 7.1% to ₩227,714Up from ₩212,667, the current price target is an average from 21 analysts. New target price is 11% above last closing price of ₩205,000. Stock is up 24% over the past year. The company is forecast to post earnings per share of ₩11,055 for next year compared to ₩7,562 last year.Valuation Update With 7 Day Price Move • May 14Investor sentiment improves as stock rises 23%After last week's 23% share price gain to ₩214,000, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 12x in the Personal Products industry in South Korea. Total returns to shareholders of 244% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩424,696 per share.分析記事 • May 09Cosmax, Inc.'s (KRX:192820) 29% Jump Shows Its Popularity With InvestorsThe Cosmax, Inc. ( KRX:192820 ) share price has done very well over the last month, posting an excellent gain of 29...分析記事 • Apr 28These 4 Measures Indicate That Cosmax (KRX:192820) Is Using Debt Reasonably WellDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...分析記事 • Mar 26We Think That There Are Issues Underlying Cosmax's (KRX:192820) EarningsCosmax, Inc. ( KRX:192820 ) announced strong profits, but the stock was stagnant. Our analysis suggests that this might...New Risk • Mar 23New minor risk - Dividend sustainabilityThe dividend is not well covered by cash flows. The company is paying a dividend despite having no free cash flows. Dividend yield: 1.3% This is considered a minor risk. Dividends are ultimately paid out of the company's available cash reserves. Companies that pay out too much of their cash flow are at risk of having to reduce or cut their dividend in future. If cash flow growth slows or cash flows fall, then there may not be enough cash reserves to maintain the same dividend. Or in extreme cases, companies may opt to take on debt to maintain the dividend. This risk is mitigated by the fact the dividend is covered by earnings, however, cash flows are generally more important. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (10% operating cash flow to total debt). High level of non-cash earnings (24% accrual ratio). Minor Risk Paying a dividend despite having no free cash flows.Reported Earnings • Mar 21Full year 2024 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2024 results: EPS: ₩7,562 (up from ₩5,036 in FY 2023). Revenue: ₩2.17t (up 22% from FY 2023). Net income: ₩85.8b (up 50% from FY 2023). Profit margin: 4.0% (up from 3.2% in FY 2023). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 1.9%. Earnings per share (EPS) missed analyst estimates by 11%. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Personal Products industry in South Korea. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 30% per year, which means it is tracking significantly ahead of earnings growth.分析記事 • Mar 19With Cosmax, Inc. (KRX:192820) It Looks Like You'll Get What You Pay ForWhen close to half the companies in Korea have price-to-earnings ratios (or "P/E's") below 12x, you may consider...お知らせ • Mar 06Cosmax, Inc., Annual General Meeting, Mar 27, 2025Cosmax, Inc., Annual General Meeting, Mar 27, 2025, at 09:00 Tokyo Standard Time. Location: conference room, 46, jeyak gongdan2-gil, hyangnam-eup, gyeonggi-do, hwaseong South KoreaPrice Target Changed • Mar 04Price target increased by 7.5% to ₩208,300Up from ₩193,789, the current price target is an average from 20 analysts. New target price is 25% above last closing price of ₩166,100. Stock is up 58% over the past year. The company is forecast to post earnings per share of ₩8,488 for next year compared to ₩5,036 last year.分析記事 • Jan 20We Think Cosmax (KRX:192820) Can Stay On Top Of Its DebtHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...分析記事 • Dec 15Cosmax (KRX:192820) Might Have The Makings Of A Multi-BaggerThere are a few key trends to look for if we want to identify the next multi-bagger. In a perfect world, we'd like to...分析記事 • Nov 27Getting In Cheap On Cosmax, Inc. (KRX:192820) Might Be DifficultCosmax, Inc.'s ( KRX:192820 ) price-to-earnings (or "P/E") ratio of 19.9x might make it look like a strong sell right...Valuation Update With 7 Day Price Move • Nov 01Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₩153,900, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 11x in the Personal Products industry in South Korea. Total returns to shareholders of 29% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩288,839 per share.Valuation Update With 7 Day Price Move • Sep 30Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₩145,500, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 14x in the Personal Products industry in South Korea. Total returns to shareholders of 21% over the past three years.分析記事 • Sep 13There's Been No Shortage Of Growth Recently For Cosmax's (KRX:192820) Returns On CapitalIf you're looking for a multi-bagger, there's a few things to keep an eye out for. Amongst other things, we'll want to...Price Target Changed • Aug 31Price target decreased by 8.0% to ₩187,625Down from ₩204,000, the current price target is an average from 16 analysts. New target price is 55% above last closing price of ₩121,300. Stock is down 20% over the past year. The company is forecast to post earnings per share of ₩9,550 for next year compared to ₩5,036 last year.分析記事 • Aug 07Cosmax, Inc. (KRX:192820) Stocks Pounded By 32% But Not Lagging Market On Growth Or PricingCosmax, Inc. ( KRX:192820 ) shareholders won't be pleased to see that the share price has had a very rough month...Valuation Update With 7 Day Price Move • Aug 05Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₩128,700, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 14x in the Personal Products industry in South Korea. Total returns to shareholders of 7.0% over the past three years.New Risk • Jul 29New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 7.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks High level of debt (61% net debt to equity). Share price has been volatile over the past 3 months (7.6% average weekly change).Valuation Update With 7 Day Price Move • Jul 19Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to ₩147,700, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 15x in the Personal Products industry in South Korea. Total returns to shareholders of 15% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩288,767 per share.分析記事 • Jul 19Cosmax, Inc. (KRX:192820) Shares Could Be 43% Below Their Intrinsic Value EstimateKey Insights The projected fair value for Cosmax is ₩294,340 based on 2 Stage Free Cash Flow to Equity Current share...Price Target Changed • Jul 17Price target increased by 7.6% to ₩213,000Up from ₩198,000, the current price target is an average from 16 analysts. New target price is 20% above last closing price of ₩178,200. Stock is up 87% over the past year. The company is forecast to post earnings per share of ₩10,778 for next year compared to ₩5,036 last year.Buy Or Sell Opportunity • Jul 01Now 24% undervaluedOver the last 90 days, the stock has risen 48% to ₩189,100. The fair value is estimated to be ₩250,445, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.7% over the last 3 years. Earnings per share has declined by 6.6%. Revenue is forecast to grow by 34% in 2 years. Earnings are forecast to grow by 118% in the next 2 years.Buy Or Sell Opportunity • Jun 20Now 24% undervaluedOver the last 90 days, the stock has risen 57% to ₩177,700. The fair value is estimated to be ₩233,143, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.7% over the last 3 years. Earnings per share has declined by 6.6%. Revenue is forecast to grow by 34% in 2 years. Earnings are forecast to grow by 117% in the next 2 years.分析記事 • Jun 18Does Cosmax (KRX:192820) Have A Healthy Balance Sheet?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Valuation Update With 7 Day Price Move • Jun 14Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₩188,600, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 16x in the Personal Products industry in South Korea. Total returns to shareholders of 42% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩232,865 per share.分析記事 • May 21Why Investors Shouldn't Be Surprised By Cosmax, Inc.'s (KRX:192820) 28% Share Price SurgeCosmax, Inc. ( KRX:192820 ) shares have continued their recent momentum with a 28% gain in the last month alone. The...Valuation Update With 7 Day Price Move • May 15Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₩160,500, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 15x in the Personal Products industry in South Korea. Total returns to shareholders of 32% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩184,606 per share.Buy Or Sell Opportunity • Apr 26Now 20% overvalued after recent price riseOver the last 90 days, the stock has risen 8.4% to ₩134,500. The fair value is estimated to be ₩111,627, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 7.2% over the last 3 years. Earnings per share has declined by 7.4%. For the next 3 years, revenue is forecast to grow by 14% per annum. Earnings are also forecast to grow by 30% per annum over the same time period.Buy Or Sell Opportunity • Apr 19Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 12% to ₩135,300. The fair value is estimated to be ₩110,546, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 7.2% over the last 3 years. Earnings per share has declined by 7.4%. For the next 3 years, revenue is forecast to grow by 14% per annum. Earnings are also forecast to grow by 30% per annum over the same time period.分析記事 • Apr 18We Like These Underlying Return On Capital Trends At Cosmax (KRX:192820)What trends should we look for it we want to identify stocks that can multiply in value over the long term? Typically...分析記事 • Mar 27Statutory Profit Doesn't Reflect How Good Cosmax's (KRX:192820) Earnings AreCosmax, Inc.'s ( KRX:192820 ) strong earnings report was rewarded with a positive stock price move. We did some digging...分析記事 • Mar 20Cosmax, Inc.'s (KRX:192820) Share Price Matching Investor OpinionWhen close to half the companies in Korea have price-to-earnings ratios (or "P/E's") below 14x, you may consider...分析記事 • Feb 29We Think Cosmax (KRX:192820) Is Taking Some Risk With Its DebtLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Major Estimate Revision • Nov 14Consensus EPS estimates fall by 11%The consensus outlook for fiscal year 2023 has been updated. 2023 EPS estimate fell from ₩8,136 to ₩7,241 per share. Revenue forecast steady at ₩1.81b. Net income forecast to grow 232% next year vs 78% growth forecast for Personal Products industry in South Korea. Consensus price target of ₩163,533 unchanged from last update. Share price fell 12% to ₩121,300 over the past week.Valuation Update With 7 Day Price Move • Oct 18Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₩131,400, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 17x in the Personal Products industry in South Korea. Total returns to shareholders of 12% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩81,014 per share.Major Estimate Revision • Aug 12Consensus EPS estimates increase by 11%The consensus outlook for earnings per share (EPS) in fiscal year 2023 has improved. 2023 revenue forecast increased from ₩1.79b to ₩1.84b. EPS estimate increased from ₩6,844 to ₩7,573 per share. Net income forecast to grow 625% next year vs 125% growth forecast for Personal Products industry in South Korea. Consensus price target up from ₩118,714 to ₩141,786. Share price rose 28% to ₩133,100 over the past week.Price Target Changed • Aug 11Price target increased by 11% to ₩132,214Up from ₩118,714, the current price target is an average from 14 analysts. New target price is approximately in line with last closing price of ₩133,100. Stock is up 97% over the past year. The company is forecast to post earnings per share of ₩6,982 for next year compared to ₩1,838 last year.Price Target Changed • Jul 22Price target increased by 7.7% to ₩117,571Up from ₩109,214, the current price target is an average from 14 analysts. New target price is 20% above last closing price of ₩98,000. Stock is up 38% over the past year. The company is forecast to post earnings per share of ₩6,844 for next year compared to ₩1,838 last year.Price Target Changed • Jun 01Price target increased by 8.2% to ₩108,143Up from ₩99,917, the current price target is an average from 14 analysts. New target price is 33% above last closing price of ₩81,100. Stock is up 17% over the past year. The company is forecast to post earnings per share of ₩6,595 for next year compared to ₩1,838 last year.Valuation Update With 7 Day Price Move • May 16Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₩87,200, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 19x in the Personal Products industry in South Korea. Total loss to shareholders of 6.5% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩89,945 per share.Valuation Update With 7 Day Price Move • Apr 26Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₩71,400, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 20x in the Personal Products industry in South Korea. Total loss to shareholders of 17% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩141,805 per share.Reported Earnings • Mar 26Full year 2022 earnings: EPS misses analyst expectationsFull year 2022 results: EPS: ₩1,838 (down from ₩6,944 in FY 2021). Revenue: ₩1.60t (flat on FY 2021). Net income: ₩20.8b (down 72% from FY 2021). Profit margin: 1.3% (down from 4.7% in FY 2021). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 54%. Revenue is forecast to grow 9.7% p.a. on average during the next 3 years, compared to a 8.9% growth forecast for the Personal Products industry in South Korea. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.Price Target Changed • Mar 11Price target increased by 8.0% to ₩94,923Up from ₩87,923, the current price target is an average from 13 analysts. New target price is 18% above last closing price of ₩80,400. Stock is down 6.0% over the past year. The company is forecast to post earnings per share of ₩3,984 for next year compared to ₩6,944 last year.Major Estimate Revision • Jan 27Consensus EPS estimates fall by 11%The consensus outlook for fiscal year 2022 has been updated. 2022 EPS estimate fell from ₩4,579 to ₩4,062 per share. Revenue forecast steady at ₩1.62b. Net income forecast to grow 26% next year vs 122% growth forecast for Personal Products industry in South Korea. Consensus price target up from ₩83,692 to ₩87,000. Share price rose 2.0% to ₩79,900 over the past week.Upcoming Dividend • Dec 21Upcoming dividend of ₩550 per shareEligible shareholders must have bought the stock before 28 December 2022. Payment date: 07 April 2023. Payout ratio is a comfortable 12% but the company is paying out more than the cash it is generating. Trailing yield: 0.8%. Lower than top quartile of South Korean dividend payers (3.3%). Lower than average of industry peers (1.3%).Price Target Changed • Dec 14Price target decreased to ₩75,692Down from ₩81,571, the current price target is an average from 13 analysts. New target price is 13% above last closing price of ₩67,000. Stock is down 34% over the past year. The company is forecast to post earnings per share of ₩4,524 for next year compared to ₩6,944 last year.Valuation Update With 7 Day Price Move • Dec 05Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₩67,000, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 14x in the Personal Products industry in South Korea. Total loss to shareholders of 11% over the past three years.Major Estimate Revision • Nov 16Consensus EPS estimates fall by 12%The consensus outlook for earnings per share (EPS) in 2022 has deteriorated. 2022 revenue forecast decreased from ₩1.66b to ₩1.62b. EPS estimate also fell from ₩4,954 per share to ₩4,372 per share. Net income forecast to grow 20% next year vs 41% growth forecast for Personal Products industry in South Korea. Consensus price target down from ₩81,571 to ₩77,231. Share price rose 14% to ₩59,100 over the past week.Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 1 independent director (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Valuation Update With 7 Day Price Move • Oct 13Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ₩42,550, the stock trades at a forward P/E ratio of 7x. Average forward P/E is 13x in the Personal Products industry in South Korea. Total loss to shareholders of 39% over the past three years.Price Target Changed • Oct 12Price target decreased to ₩93,357Down from ₩101,286, the current price target is an average from 14 analysts. New target price is 114% above last closing price of ₩43,550. Stock is down 67% over the past year. The company is forecast to post earnings per share of ₩5,160 for next year compared to ₩6,944 last year.Price Target Changed • Oct 08Price target decreased to ₩97,357Down from ₩107,571, the current price target is an average from 14 analysts. New target price is 97% above last closing price of ₩49,450. Stock is down 63% over the past year. The company is forecast to post earnings per share of ₩5,187 for next year compared to ₩6,944 last year.Valuation Update With 7 Day Price Move • Sep 29Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ₩51,500, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 14x in the Personal Products industry in South Korea. Total loss to shareholders of 28% over the past three years.Price Target Changed • May 19Price target decreased to ₩120,267Down from ₩131,938, the current price target is an average from 15 analysts. New target price is 89% above last closing price of ₩63,800. Stock is down 47% over the past year. The company is forecast to post earnings per share of ₩5,492 for next year compared to ₩6,944 last year.Valuation Update With 7 Day Price Move • May 18Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to ₩63,500, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 13x in the Personal Products industry in South Korea. Total loss to shareholders of 41% over the past three years.Major Estimate Revision • May 17Consensus EPS estimates fall by 37%The consensus outlook for earnings per share (EPS) in 2022 has deteriorated. 2022 revenue forecast decreased from ₩1.75b to ₩1.68b. EPS estimate also fell from ₩7,613 per share to ₩4,790 per share. Net income forecast to shrink 25% next year vs 22% growth forecast for Personal Products industry in South Korea . Consensus price target down from ₩131,938 to ₩124,933. Share price fell 18% to ₩63,600 over the past week.Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 1 independent director (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Price Target Changed • Mar 10Price target decreased to ₩147,118Down from ₩159,125, the current price target is an average from 17 analysts. New target price is 75% above last closing price of ₩83,900. Stock is down 25% over the past year. The company is forecast to post earnings per share of ₩6,416 for next year compared to ₩2,128 last year.Buying Opportunity • Jan 19Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 43%. The fair value is estimated to be ₩93,653, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 6.5% per annum over the last 3 years. Earnings per share has grown by 12% per annum over the last 3 years.Valuation Update With 7 Day Price Move • Dec 21Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ₩84,700, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 11x in the Personal Products industry in South Korea. Total loss to shareholders of 30% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩102,416 per share.Price Target Changed • Aug 15Price target increased to ₩173,150Up from ₩161,632, the current price target is an average from 19 analysts. New target price is 30% above last closing price of ₩133,000. Stock is up 16% over the past year.お知らせ • Jun 26Cosmax, Inc. has completed a Follow-on Equity Offering in the amount of KRW 133.9 billion.Cosmax, Inc. has completed a Follow-on Equity Offering in the amount of KRW 133.9 billion. Security Name: Common Stock Security Type: Common Stock Securities Offered: 1,300,000 Price\Range: KRW 103000 Transaction Features: ESOP Related Offering; Rights OfferingValuation Update With 7 Day Price Move • Apr 28Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to ₩111,500, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 20x in the Personal Products industry in South Korea. Total loss to shareholders of 28% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩110,448 per share.分析記事 • Apr 16Does Cosmax (KRX:192820) Have A Healthy Balance Sheet?Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...分析記事 • Mar 25Investors Can Find Comfort In Cosmax's (KRX:192820) Earnings QualityThe market for Cosmax, Inc.'s ( KRX:192820 ) shares didn't move much after it posted weak earnings recently. Our...分析記事 • Mar 10Will Cosmax (KRX:192820) Multiply In Value Going Forward?If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...株主還元A192820KR Personal ProductsKR 市場7D1.7%-0.9%10.4%1Y-13.1%23.2%188.7%株主還元を見る業界別リターン: A192820過去 1 年間で23.2 % の収益を上げたKR Personal Products業界を下回りました。リターン対市場: A192820は、過去 1 年間で188.7 % のリターンを上げたKR市場を下回りました。価格変動Is A192820's price volatile compared to industry and market?A192820 volatilityA192820 Average Weekly Movement9.0%Personal Products Industry Average Movement8.8%Market Average Movement9.5%10% most volatile stocks in KR Market16.6%10% least volatile stocks in KR Market4.9%安定した株価: A192820 、 KR市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。時間の経過による変動: A192820の 週次ボラティリティ ( 9% ) は過去 1 年間安定しています。会社概要設立従業員CEO（最高経営責任者ウェブサイト19921,535Jae-Cheon Kimwww.cosmax.comは、韓国内外で化粧品および健康機能食品の研究、開発、生産、製造を行っている。化粧品事業、受託化粧品事業、その他事業を展開。同社は、Capsule+、IS-LCE、CeraPresso、Emulixir、Foamology、IRPT、Solar Clearブランドのスキンケア製品、Air Cloud、skin fabricブランドのベースメイク、Xfine、JellTeX、ARTCOTTA、Bi-Coat、creamline、Thixolash、CRYSTAL PRISMブランドのメイクアップ、Ginsenologyブランドの漢方薬、Scenteritageブランドのフレグランス、ヘアケア製品を提供している。旧社名は韓国ミロトで、1994年に社名をコスマックス社に変更した。コスマックス社は1992年に設立され、韓国の華城市に本社を置いている。もっと見るCosmax, Inc. 基礎のまとめCosmax の収益と売上を時価総額と比較するとどうか。A192820 基礎統計学時価総額₩2.06t収益（TTM）₩156.51b売上高(TTM)₩2.49t12.8xPER（株価収益率0.8xP/SレシオA192820 は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計A192820 損益計算書（TTM）収益₩2.49t売上原価₩2.07t売上総利益₩418.48bその他の費用₩261.97b収益₩156.51b直近の収益報告Mar 31, 2026次回決算日該当なし一株当たり利益（EPS）13.79kグロス・マージン16.79%純利益率6.28%有利子負債／自己資本比率147.7%A192820 の長期的なパフォーマンスは？過去の実績と比較を見る配当金1.9%現在の配当利回り24%配当性向View Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/27 09:51終値2026/05/27 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Cosmax, Inc. 24 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。34 アナリスト機関Hyung-Joon MoonBarclaysJung Ae ChunBofA Global ResearchHyeryeong KimCGS International31 その他のアナリストを表示
Valuation Update With 7 Day Price Move • May 18Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to ₩180,200, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 14x in the Personal Products industry in South Korea. Total returns to shareholders of 115% over the past three years.
分析記事 • Mar 25Cosmax's (KRX:192820) Solid Profits Have Weak FundamentalsCosmax, Inc.'s ( KRX:192820 ) stock was strong after they recently reported robust earnings. However, our analysis...
Reported Earnings • Mar 24Full year 2025 earnings: EPS exceeds analyst expectationsFull year 2025 results: EPS: ₩10,847 (up from ₩7,562 in FY 2024). Revenue: ₩2.40t (up 11% from FY 2024). Net income: ₩123.1b (up 43% from FY 2024). Profit margin: 5.1% (up from 4.0% in FY 2024). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 95%. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 17% growth forecast for the Personal Products industry in South Korea. Over the last 3 years on average, earnings per share has increased by 41% per year but the company’s share price has only increased by 34% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Mar 23Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₩198,700, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 14x in the Personal Products industry in South Korea. Total returns to shareholders of 157% over the past three years.
お知らせ • Mar 07+ 1 more updateCosmax, Inc. announces Annual dividendCosmax, Inc. announced Annual dividend of KRW 3300.0000 per share, ex-date on March 30, 2026 and record date on March 31, 2026.
Valuation Update With 7 Day Price Move • Mar 04Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₩160,700, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 14x in the Personal Products industry in South Korea. Total returns to shareholders of 102% over the past three years.
Valuation Update With 7 Day Price Move • May 18Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to ₩180,200, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 14x in the Personal Products industry in South Korea. Total returns to shareholders of 115% over the past three years.
分析記事 • Mar 25Cosmax's (KRX:192820) Solid Profits Have Weak FundamentalsCosmax, Inc.'s ( KRX:192820 ) stock was strong after they recently reported robust earnings. However, our analysis...
Reported Earnings • Mar 24Full year 2025 earnings: EPS exceeds analyst expectationsFull year 2025 results: EPS: ₩10,847 (up from ₩7,562 in FY 2024). Revenue: ₩2.40t (up 11% from FY 2024). Net income: ₩123.1b (up 43% from FY 2024). Profit margin: 5.1% (up from 4.0% in FY 2024). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 95%. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 17% growth forecast for the Personal Products industry in South Korea. Over the last 3 years on average, earnings per share has increased by 41% per year but the company’s share price has only increased by 34% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Mar 23Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₩198,700, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 14x in the Personal Products industry in South Korea. Total returns to shareholders of 157% over the past three years.
お知らせ • Mar 07+ 1 more updateCosmax, Inc. announces Annual dividendCosmax, Inc. announced Annual dividend of KRW 3300.0000 per share, ex-date on March 30, 2026 and record date on March 31, 2026.
Valuation Update With 7 Day Price Move • Mar 04Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₩160,700, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 14x in the Personal Products industry in South Korea. Total returns to shareholders of 102% over the past three years.
お知らせ • Feb 23Cosmax, Inc. (KOSE:A192820) signed a share purchase agreement to acquire 51% stake in Keminova Italiana A Responsabilita' Limitata Benefit In Breve Keminova Italiana S.B. Srl.Cosmax, Inc. (KOSE:A192820) signed a share purchase agreement to acquire 51% stake in Keminova Italiana A Responsabilita' Limitata Benefit In Breve Keminova Italiana S.B. Srl on February 23, 2026. Through this acquisition, COSMAX seeks to leverage the strengths of both companies to create significant synergies. For the period ending December 31, 2025, Keminova Italiana A Responsabilita' Limitata Benefit In Breve Keminova Italiana S.B. Srl reported total revenue of €10.5 million. COSMAX plans to satisfy the conditions precedent, including securing approval from the Italian government, by March, to finalize the transaction.
Major Estimate Revision • Jan 27Consensus EPS estimates fall by 16%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate fell from ₩6,824 to ₩5,749 per share. Revenue forecast steady at ₩2.40b. Net income forecast to grow 149% next year vs 61% growth forecast for Personal Products industry in South Korea. Consensus price target broadly unchanged at ₩242,500. Share price rose 2.9% to ₩189,600 over the past week.
分析記事 • Jan 02These 4 Measures Indicate That Cosmax (KRX:192820) Is Using Debt ExtensivelyHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
分析記事 • Dec 17Why Investors Shouldn't Be Surprised By Cosmax, Inc.'s (KRX:192820) P/EWhen close to half the companies in Korea have price-to-earnings ratios (or "P/E's") below 13x, you may consider...
分析記事 • Nov 20We Like Cosmax's (KRX:192820) Returns And Here's How They're TrendingIf you're looking for a multi-bagger, there's a few things to keep an eye out for. One common approach is to try and...
Reported Earnings • Nov 19Third quarter 2025 earnings: EPS and revenues miss analyst expectationsThird quarter 2025 results: EPS: ₩789 (down from ₩1,856 in 3Q 2024). Revenue: ₩585.6b (up 11% from 3Q 2024). Net income: ₩8.96b (down 57% from 3Q 2024). Profit margin: 1.5% (down from 4.0% in 3Q 2024). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 1.9%. Earnings per share (EPS) also missed analyst estimates by 76%. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Personal Products industry in South Korea. Over the last 3 years on average, earnings per share has increased by 29% per year but the company’s share price has increased by 41% per year, which means it is tracking significantly ahead of earnings growth.
Price Target Changed • Nov 12Price target decreased by 10% to ₩256,280Down from ₩285,600, the current price target is an average from 25 analysts. New target price is 62% above last closing price of ₩158,000. Stock is up 19% over the past year. The company is forecast to post earnings per share of ₩6,484 for next year compared to ₩7,562 last year.
Major Estimate Revision • Nov 11Consensus EPS estimates fall by 28%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate fell from ₩9,309 to ₩6,713 per share. Revenue forecast steady at ₩2.45b. Net income forecast to grow 92% next year vs 72% growth forecast for Personal Products industry in South Korea. Consensus price target broadly unchanged at ₩280,160. Share price fell 22% to ₩156,500 over the past week.
分析記事 • Nov 05When Should You Buy Cosmax, Inc. (KRX:192820)?Cosmax, Inc. ( KRX:192820 ), is not the largest company out there, but it saw significant share price movement during...
分析記事 • Sep 17Is Cosmax, Inc. (KRX:192820) Trading At A 47% Discount?Key Insights Cosmax's estimated fair value is ₩417,766 based on 2 Stage Free Cash Flow to Equity Cosmax's ₩222,500...
分析記事 • Sep 03These 4 Measures Indicate That Cosmax (KRX:192820) Is Using Debt Reasonably WellLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
New Risk • Aug 19New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 23% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (2.6% operating cash flow to total debt). High level of non-cash earnings (23% accrual ratio). Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (8.6% average weekly change).
Reported Earnings • Aug 19Second quarter 2025 earnings: EPS and revenues miss analyst expectationsSecond quarter 2025 results: EPS: ₩1,844 (down from ₩2,965 in 2Q 2024). Revenue: ₩623.6b (up 13% from 2Q 2024). Net income: ₩20.9b (down 38% from 2Q 2024). Profit margin: 3.4% (down from 6.1% in 2Q 2024). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 3.7%. Earnings per share (EPS) also missed analyst estimates by 38%. Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Personal Products industry in South Korea. Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has increased by 47% per year, which means it is tracking significantly ahead of earnings growth.
分析記事 • Aug 14What You Can Learn From Cosmax, Inc.'s (KRX:192820) P/E After Its 27% Share Price CrashKOSE:A192820 1 Year Share Price vs Fair Value Explore Cosmax's Fair Values from the Community and select yours Cosmax...
Major Estimate Revision • Aug 13Consensus EPS estimates fall by 10%The consensus outlook for earnings per share (EPS) in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from ₩2.55b to ₩2.52b. EPS estimate also fell from ₩11,353 per share to ₩10,172 per share. Net income forecast to grow 67% next year vs 32% growth forecast for Personal Products industry in South Korea. Consensus price target down from ₩295,167 to ₩288,000. Share price fell 25% to ₩191,600 over the past week.
Valuation Update With 7 Day Price Move • Aug 12Investor sentiment deteriorates as stock falls 22%After last week's 22% share price decline to ₩196,600, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 17x in the Personal Products industry in South Korea. Total returns to shareholders of 188% over the past three years.
分析記事 • Aug 04We Think Cosmax (KRX:192820) Might Have The DNA Of A Multi-BaggerIf we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
分析記事 • Jul 21When Should You Buy Cosmax, Inc. (KRX:192820)?Cosmax, Inc. ( KRX:192820 ), might not be a large cap stock, but it led the KOSE gainers with a relatively large price...
分析記事 • Jun 23Why Investors Shouldn't Be Surprised By Cosmax, Inc.'s (KRX:192820) 29% Share Price SurgeDespite an already strong run, Cosmax, Inc. ( KRX:192820 ) shares have been powering on, with a gain of 29% in the last...
Valuation Update With 7 Day Price Move • Jun 20Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₩278,500, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 14x in the Personal Products industry in South Korea. Total returns to shareholders of 397% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩393,577 per share.
Price Target Changed • Jun 18Price target increased by 9.5% to ₩261,571Up from ₩238,952, the current price target is an average from 21 analysts. New target price is approximately in line with last closing price of ₩262,000. Stock is up 40% over the past year. The company is forecast to post earnings per share of ₩11,419 for next year compared to ₩7,562 last year.
Price Target Changed • May 19Price target increased by 7.1% to ₩227,714Up from ₩212,667, the current price target is an average from 21 analysts. New target price is 11% above last closing price of ₩205,000. Stock is up 24% over the past year. The company is forecast to post earnings per share of ₩11,055 for next year compared to ₩7,562 last year.
Valuation Update With 7 Day Price Move • May 14Investor sentiment improves as stock rises 23%After last week's 23% share price gain to ₩214,000, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 12x in the Personal Products industry in South Korea. Total returns to shareholders of 244% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩424,696 per share.
分析記事 • May 09Cosmax, Inc.'s (KRX:192820) 29% Jump Shows Its Popularity With InvestorsThe Cosmax, Inc. ( KRX:192820 ) share price has done very well over the last month, posting an excellent gain of 29...
分析記事 • Apr 28These 4 Measures Indicate That Cosmax (KRX:192820) Is Using Debt Reasonably WellDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
分析記事 • Mar 26We Think That There Are Issues Underlying Cosmax's (KRX:192820) EarningsCosmax, Inc. ( KRX:192820 ) announced strong profits, but the stock was stagnant. Our analysis suggests that this might...
New Risk • Mar 23New minor risk - Dividend sustainabilityThe dividend is not well covered by cash flows. The company is paying a dividend despite having no free cash flows. Dividend yield: 1.3% This is considered a minor risk. Dividends are ultimately paid out of the company's available cash reserves. Companies that pay out too much of their cash flow are at risk of having to reduce or cut their dividend in future. If cash flow growth slows or cash flows fall, then there may not be enough cash reserves to maintain the same dividend. Or in extreme cases, companies may opt to take on debt to maintain the dividend. This risk is mitigated by the fact the dividend is covered by earnings, however, cash flows are generally more important. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (10% operating cash flow to total debt). High level of non-cash earnings (24% accrual ratio). Minor Risk Paying a dividend despite having no free cash flows.
Reported Earnings • Mar 21Full year 2024 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2024 results: EPS: ₩7,562 (up from ₩5,036 in FY 2023). Revenue: ₩2.17t (up 22% from FY 2023). Net income: ₩85.8b (up 50% from FY 2023). Profit margin: 4.0% (up from 3.2% in FY 2023). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 1.9%. Earnings per share (EPS) missed analyst estimates by 11%. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Personal Products industry in South Korea. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 30% per year, which means it is tracking significantly ahead of earnings growth.
分析記事 • Mar 19With Cosmax, Inc. (KRX:192820) It Looks Like You'll Get What You Pay ForWhen close to half the companies in Korea have price-to-earnings ratios (or "P/E's") below 12x, you may consider...
お知らせ • Mar 06Cosmax, Inc., Annual General Meeting, Mar 27, 2025Cosmax, Inc., Annual General Meeting, Mar 27, 2025, at 09:00 Tokyo Standard Time. Location: conference room, 46, jeyak gongdan2-gil, hyangnam-eup, gyeonggi-do, hwaseong South Korea
Price Target Changed • Mar 04Price target increased by 7.5% to ₩208,300Up from ₩193,789, the current price target is an average from 20 analysts. New target price is 25% above last closing price of ₩166,100. Stock is up 58% over the past year. The company is forecast to post earnings per share of ₩8,488 for next year compared to ₩5,036 last year.
分析記事 • Jan 20We Think Cosmax (KRX:192820) Can Stay On Top Of Its DebtHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
分析記事 • Dec 15Cosmax (KRX:192820) Might Have The Makings Of A Multi-BaggerThere are a few key trends to look for if we want to identify the next multi-bagger. In a perfect world, we'd like to...
分析記事 • Nov 27Getting In Cheap On Cosmax, Inc. (KRX:192820) Might Be DifficultCosmax, Inc.'s ( KRX:192820 ) price-to-earnings (or "P/E") ratio of 19.9x might make it look like a strong sell right...
Valuation Update With 7 Day Price Move • Nov 01Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₩153,900, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 11x in the Personal Products industry in South Korea. Total returns to shareholders of 29% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩288,839 per share.
Valuation Update With 7 Day Price Move • Sep 30Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₩145,500, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 14x in the Personal Products industry in South Korea. Total returns to shareholders of 21% over the past three years.
分析記事 • Sep 13There's Been No Shortage Of Growth Recently For Cosmax's (KRX:192820) Returns On CapitalIf you're looking for a multi-bagger, there's a few things to keep an eye out for. Amongst other things, we'll want to...
Price Target Changed • Aug 31Price target decreased by 8.0% to ₩187,625Down from ₩204,000, the current price target is an average from 16 analysts. New target price is 55% above last closing price of ₩121,300. Stock is down 20% over the past year. The company is forecast to post earnings per share of ₩9,550 for next year compared to ₩5,036 last year.
分析記事 • Aug 07Cosmax, Inc. (KRX:192820) Stocks Pounded By 32% But Not Lagging Market On Growth Or PricingCosmax, Inc. ( KRX:192820 ) shareholders won't be pleased to see that the share price has had a very rough month...
Valuation Update With 7 Day Price Move • Aug 05Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₩128,700, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 14x in the Personal Products industry in South Korea. Total returns to shareholders of 7.0% over the past three years.
New Risk • Jul 29New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 7.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks High level of debt (61% net debt to equity). Share price has been volatile over the past 3 months (7.6% average weekly change).
Valuation Update With 7 Day Price Move • Jul 19Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to ₩147,700, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 15x in the Personal Products industry in South Korea. Total returns to shareholders of 15% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩288,767 per share.
分析記事 • Jul 19Cosmax, Inc. (KRX:192820) Shares Could Be 43% Below Their Intrinsic Value EstimateKey Insights The projected fair value for Cosmax is ₩294,340 based on 2 Stage Free Cash Flow to Equity Current share...
Price Target Changed • Jul 17Price target increased by 7.6% to ₩213,000Up from ₩198,000, the current price target is an average from 16 analysts. New target price is 20% above last closing price of ₩178,200. Stock is up 87% over the past year. The company is forecast to post earnings per share of ₩10,778 for next year compared to ₩5,036 last year.
Buy Or Sell Opportunity • Jul 01Now 24% undervaluedOver the last 90 days, the stock has risen 48% to ₩189,100. The fair value is estimated to be ₩250,445, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.7% over the last 3 years. Earnings per share has declined by 6.6%. Revenue is forecast to grow by 34% in 2 years. Earnings are forecast to grow by 118% in the next 2 years.
Buy Or Sell Opportunity • Jun 20Now 24% undervaluedOver the last 90 days, the stock has risen 57% to ₩177,700. The fair value is estimated to be ₩233,143, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.7% over the last 3 years. Earnings per share has declined by 6.6%. Revenue is forecast to grow by 34% in 2 years. Earnings are forecast to grow by 117% in the next 2 years.
分析記事 • Jun 18Does Cosmax (KRX:192820) Have A Healthy Balance Sheet?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Valuation Update With 7 Day Price Move • Jun 14Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₩188,600, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 16x in the Personal Products industry in South Korea. Total returns to shareholders of 42% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩232,865 per share.
分析記事 • May 21Why Investors Shouldn't Be Surprised By Cosmax, Inc.'s (KRX:192820) 28% Share Price SurgeCosmax, Inc. ( KRX:192820 ) shares have continued their recent momentum with a 28% gain in the last month alone. The...
Valuation Update With 7 Day Price Move • May 15Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₩160,500, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 15x in the Personal Products industry in South Korea. Total returns to shareholders of 32% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩184,606 per share.
Buy Or Sell Opportunity • Apr 26Now 20% overvalued after recent price riseOver the last 90 days, the stock has risen 8.4% to ₩134,500. The fair value is estimated to be ₩111,627, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 7.2% over the last 3 years. Earnings per share has declined by 7.4%. For the next 3 years, revenue is forecast to grow by 14% per annum. Earnings are also forecast to grow by 30% per annum over the same time period.
Buy Or Sell Opportunity • Apr 19Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 12% to ₩135,300. The fair value is estimated to be ₩110,546, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 7.2% over the last 3 years. Earnings per share has declined by 7.4%. For the next 3 years, revenue is forecast to grow by 14% per annum. Earnings are also forecast to grow by 30% per annum over the same time period.
分析記事 • Apr 18We Like These Underlying Return On Capital Trends At Cosmax (KRX:192820)What trends should we look for it we want to identify stocks that can multiply in value over the long term? Typically...
分析記事 • Mar 27Statutory Profit Doesn't Reflect How Good Cosmax's (KRX:192820) Earnings AreCosmax, Inc.'s ( KRX:192820 ) strong earnings report was rewarded with a positive stock price move. We did some digging...
分析記事 • Mar 20Cosmax, Inc.'s (KRX:192820) Share Price Matching Investor OpinionWhen close to half the companies in Korea have price-to-earnings ratios (or "P/E's") below 14x, you may consider...
分析記事 • Feb 29We Think Cosmax (KRX:192820) Is Taking Some Risk With Its DebtLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Major Estimate Revision • Nov 14Consensus EPS estimates fall by 11%The consensus outlook for fiscal year 2023 has been updated. 2023 EPS estimate fell from ₩8,136 to ₩7,241 per share. Revenue forecast steady at ₩1.81b. Net income forecast to grow 232% next year vs 78% growth forecast for Personal Products industry in South Korea. Consensus price target of ₩163,533 unchanged from last update. Share price fell 12% to ₩121,300 over the past week.
Valuation Update With 7 Day Price Move • Oct 18Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₩131,400, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 17x in the Personal Products industry in South Korea. Total returns to shareholders of 12% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩81,014 per share.
Major Estimate Revision • Aug 12Consensus EPS estimates increase by 11%The consensus outlook for earnings per share (EPS) in fiscal year 2023 has improved. 2023 revenue forecast increased from ₩1.79b to ₩1.84b. EPS estimate increased from ₩6,844 to ₩7,573 per share. Net income forecast to grow 625% next year vs 125% growth forecast for Personal Products industry in South Korea. Consensus price target up from ₩118,714 to ₩141,786. Share price rose 28% to ₩133,100 over the past week.
Price Target Changed • Aug 11Price target increased by 11% to ₩132,214Up from ₩118,714, the current price target is an average from 14 analysts. New target price is approximately in line with last closing price of ₩133,100. Stock is up 97% over the past year. The company is forecast to post earnings per share of ₩6,982 for next year compared to ₩1,838 last year.
Price Target Changed • Jul 22Price target increased by 7.7% to ₩117,571Up from ₩109,214, the current price target is an average from 14 analysts. New target price is 20% above last closing price of ₩98,000. Stock is up 38% over the past year. The company is forecast to post earnings per share of ₩6,844 for next year compared to ₩1,838 last year.
Price Target Changed • Jun 01Price target increased by 8.2% to ₩108,143Up from ₩99,917, the current price target is an average from 14 analysts. New target price is 33% above last closing price of ₩81,100. Stock is up 17% over the past year. The company is forecast to post earnings per share of ₩6,595 for next year compared to ₩1,838 last year.
Valuation Update With 7 Day Price Move • May 16Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₩87,200, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 19x in the Personal Products industry in South Korea. Total loss to shareholders of 6.5% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩89,945 per share.
Valuation Update With 7 Day Price Move • Apr 26Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₩71,400, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 20x in the Personal Products industry in South Korea. Total loss to shareholders of 17% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩141,805 per share.
Reported Earnings • Mar 26Full year 2022 earnings: EPS misses analyst expectationsFull year 2022 results: EPS: ₩1,838 (down from ₩6,944 in FY 2021). Revenue: ₩1.60t (flat on FY 2021). Net income: ₩20.8b (down 72% from FY 2021). Profit margin: 1.3% (down from 4.7% in FY 2021). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 54%. Revenue is forecast to grow 9.7% p.a. on average during the next 3 years, compared to a 8.9% growth forecast for the Personal Products industry in South Korea. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.
Price Target Changed • Mar 11Price target increased by 8.0% to ₩94,923Up from ₩87,923, the current price target is an average from 13 analysts. New target price is 18% above last closing price of ₩80,400. Stock is down 6.0% over the past year. The company is forecast to post earnings per share of ₩3,984 for next year compared to ₩6,944 last year.
Major Estimate Revision • Jan 27Consensus EPS estimates fall by 11%The consensus outlook for fiscal year 2022 has been updated. 2022 EPS estimate fell from ₩4,579 to ₩4,062 per share. Revenue forecast steady at ₩1.62b. Net income forecast to grow 26% next year vs 122% growth forecast for Personal Products industry in South Korea. Consensus price target up from ₩83,692 to ₩87,000. Share price rose 2.0% to ₩79,900 over the past week.
Upcoming Dividend • Dec 21Upcoming dividend of ₩550 per shareEligible shareholders must have bought the stock before 28 December 2022. Payment date: 07 April 2023. Payout ratio is a comfortable 12% but the company is paying out more than the cash it is generating. Trailing yield: 0.8%. Lower than top quartile of South Korean dividend payers (3.3%). Lower than average of industry peers (1.3%).
Price Target Changed • Dec 14Price target decreased to ₩75,692Down from ₩81,571, the current price target is an average from 13 analysts. New target price is 13% above last closing price of ₩67,000. Stock is down 34% over the past year. The company is forecast to post earnings per share of ₩4,524 for next year compared to ₩6,944 last year.
Valuation Update With 7 Day Price Move • Dec 05Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₩67,000, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 14x in the Personal Products industry in South Korea. Total loss to shareholders of 11% over the past three years.
Major Estimate Revision • Nov 16Consensus EPS estimates fall by 12%The consensus outlook for earnings per share (EPS) in 2022 has deteriorated. 2022 revenue forecast decreased from ₩1.66b to ₩1.62b. EPS estimate also fell from ₩4,954 per share to ₩4,372 per share. Net income forecast to grow 20% next year vs 41% growth forecast for Personal Products industry in South Korea. Consensus price target down from ₩81,571 to ₩77,231. Share price rose 14% to ₩59,100 over the past week.
Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 1 independent director (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Valuation Update With 7 Day Price Move • Oct 13Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ₩42,550, the stock trades at a forward P/E ratio of 7x. Average forward P/E is 13x in the Personal Products industry in South Korea. Total loss to shareholders of 39% over the past three years.
Price Target Changed • Oct 12Price target decreased to ₩93,357Down from ₩101,286, the current price target is an average from 14 analysts. New target price is 114% above last closing price of ₩43,550. Stock is down 67% over the past year. The company is forecast to post earnings per share of ₩5,160 for next year compared to ₩6,944 last year.
Price Target Changed • Oct 08Price target decreased to ₩97,357Down from ₩107,571, the current price target is an average from 14 analysts. New target price is 97% above last closing price of ₩49,450. Stock is down 63% over the past year. The company is forecast to post earnings per share of ₩5,187 for next year compared to ₩6,944 last year.
Valuation Update With 7 Day Price Move • Sep 29Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ₩51,500, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 14x in the Personal Products industry in South Korea. Total loss to shareholders of 28% over the past three years.
Price Target Changed • May 19Price target decreased to ₩120,267Down from ₩131,938, the current price target is an average from 15 analysts. New target price is 89% above last closing price of ₩63,800. Stock is down 47% over the past year. The company is forecast to post earnings per share of ₩5,492 for next year compared to ₩6,944 last year.
Valuation Update With 7 Day Price Move • May 18Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to ₩63,500, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 13x in the Personal Products industry in South Korea. Total loss to shareholders of 41% over the past three years.
Major Estimate Revision • May 17Consensus EPS estimates fall by 37%The consensus outlook for earnings per share (EPS) in 2022 has deteriorated. 2022 revenue forecast decreased from ₩1.75b to ₩1.68b. EPS estimate also fell from ₩7,613 per share to ₩4,790 per share. Net income forecast to shrink 25% next year vs 22% growth forecast for Personal Products industry in South Korea . Consensus price target down from ₩131,938 to ₩124,933. Share price fell 18% to ₩63,600 over the past week.
Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 1 independent director (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Price Target Changed • Mar 10Price target decreased to ₩147,118Down from ₩159,125, the current price target is an average from 17 analysts. New target price is 75% above last closing price of ₩83,900. Stock is down 25% over the past year. The company is forecast to post earnings per share of ₩6,416 for next year compared to ₩2,128 last year.
Buying Opportunity • Jan 19Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 43%. The fair value is estimated to be ₩93,653, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 6.5% per annum over the last 3 years. Earnings per share has grown by 12% per annum over the last 3 years.
Valuation Update With 7 Day Price Move • Dec 21Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ₩84,700, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 11x in the Personal Products industry in South Korea. Total loss to shareholders of 30% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩102,416 per share.
Price Target Changed • Aug 15Price target increased to ₩173,150Up from ₩161,632, the current price target is an average from 19 analysts. New target price is 30% above last closing price of ₩133,000. Stock is up 16% over the past year.
お知らせ • Jun 26Cosmax, Inc. has completed a Follow-on Equity Offering in the amount of KRW 133.9 billion.Cosmax, Inc. has completed a Follow-on Equity Offering in the amount of KRW 133.9 billion. Security Name: Common Stock Security Type: Common Stock Securities Offered: 1,300,000 Price\Range: KRW 103000 Transaction Features: ESOP Related Offering; Rights Offering
Valuation Update With 7 Day Price Move • Apr 28Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to ₩111,500, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 20x in the Personal Products industry in South Korea. Total loss to shareholders of 28% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩110,448 per share.
分析記事 • Apr 16Does Cosmax (KRX:192820) Have A Healthy Balance Sheet?Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
分析記事 • Mar 25Investors Can Find Comfort In Cosmax's (KRX:192820) Earnings QualityThe market for Cosmax, Inc.'s ( KRX:192820 ) shares didn't move much after it posted weak earnings recently. Our...
分析記事 • Mar 10Will Cosmax (KRX:192820) Multiply In Value Going Forward?If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
